All News Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Market Closed - Nasdaq Other stock markets 01:30:00 30/04/2024 am IST			5-day change	1st Jan Change
18.55 ^USD	+3.75%		+8.51%	+5.76%

23/04	Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	MT
23/04	Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	23/04	MT
Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024	23/04
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Posts Q1 Revenue $79.9M, vs. Street Est of $78.5M	23/04	MT
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution	23/04	AQ
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04	CI
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024	17/04	AQ
Wedbush Adjusts Kiniksa Pharmaceuticals' PT to $30 From $28, Maintains Outperform Rating	03/04	MT
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	02/04	AQ
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	02/04	CI
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K	29/03	PU
Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase	28/02	MT
Transcript : Kiniksa Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Feb 28, 2024	28/02
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q4 Revenue $83.4M, vs. Street Est of $72.3M	28/02	MT
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution	28/02	AQ
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02	CI
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024	22/02	AQ
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for the Year 2024	09/01	CI
Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 01:30 PM	09/01
Kiniksa Pharmaceuticals Provides Corporate Update	04/01	AQ
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference	03/01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

All News

Filters